Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
-
New drug shows promise in hitting Hard-to-Treat brain cancers
Disease control OngoingThis study tests a drug called niraparib in people with two types of brain tumors: newly diagnosed glioblastoma and recurrent IDH-mutant glioma with ATRX loss. The goal is to see if the drug reaches the tumor and slows its growth. Up to 42 participants will receive niraparib befo…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug-radiation combo targets deadly brain tumors in early trial
Disease control OngoingThis early-phase trial tests whether adding the drug quisinostat to standard radiation therapy can help control glioblastoma, a fast-growing brain cancer. About 30 adults with newly diagnosed or recurrent glioblastoma will receive the drug before and during radiation. The goal is…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 15, 2026 11:54 UTC